• IBM Research

    Now entering its 70th year, IBM Research continues to define the future of information technology with more than 3,000 researchers in 12 labs located across six continents. Scientists from IBM Research have produced six Nobel Laureates, 10 U.S. National Medals of Technology; five U.S. National Medals of Science, six Turing Awards, 19 inductees in the National Academy of Sciences and 20 inductees in the U.S. National Inventors Hall of Fame.

    For more information about IBM Research's nanomedicine program, visit

    For more information about IBM Research materials development, visit

  • Critical Pharma

    Critical Pharmaceuticals is a Nottingham, UK-based biotechnology company specializing in drug delivery.  Critical Pharmaceuticals are developing a pipeline of unique biological drug products utilizing the company’s proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone that has significant advantages over existing daily injectable products and has shown equivalent bioactivity to a subcutaneous injection of marketed product in a Phase 1 clinical trial. In addition, Critical Pharmaceuticals have also developed supercritical fluid processing methodologies that enable the delivery of high value recombinantprotein and peptide therapeutics in a controlled release manner while maintaining the structure and activity of the protein (

  • Corbion logo


    Corbion is the global market leader in lactic acid, lactic acid derivatives and lactides, and a leading company in emulsifiers, functional enzyme blends, minerals and vitamins. The company delivers high performance biobased products made from renewable resources and applied in global markets such as bakery, meat, pharmaceuticals and medical devices, home and personal care, packaging, automotive, coatings and adhesives. For the plastics industry, Corbion Purac offers lactides and PLA resins for general purpose and high performance bioplastics. PLA (Poly Lactic Acid) is a biobased plastic with a low carbon footprint and is used in packaging, disposables, fibers, electronics and automotive markets. Additionally, Corbion is developing 100% biobased FDCA for high performance PEF (Polyethylene Furanoate) resin. PEF can, for example, be used for bottle and film applications due to its excellent barrier properties. In 2014, Corbion generated annual sales of € 770.1 million and had a workforce of 1,893 employees. Corbion is listed on NYSE Euronext Amsterdam.

  • BASF logo


    BASF SE is largest operating company of the BASF Group, the world’s leading chemical conglomerate: Its portfolio ranges from chemicals, materials, performance products, agricultural products and fine chemicals to crude oil and naturalgas. BASF engages in research at 33 sites in Europe alone. In addition, BASF scientists are involved in numerous alliances with leading universities, research institutes, startups, partners from industry, and customers, more than 1300 of which are based in Europe. BASF spent €1.7 billion on research and development in 2012 of which about 80 percent were invested in Europe. On a global scale, more than 10500 BASF employees are engaged in research and development, approximately 5300 of whom at BASF SE alone. Our research projects respond both to market requirements (market pull) and to current technological developments (technology push). BASF has substantial experience in EC-funded research and currently participates in more than 25 projects. (  

  • Synthomer

    Synthomer is a world-class supplier of water-based synthetic polymers to industry, with a turnover of circa €1.25bn from 33 production units, and a worldwide presence in over 90 countries (2013 results for Synthomer plc). Our product portfolio comprisespolymers for a wide variety of applications ranging from paints and adhesives to textiles, speciality paper coatings, plastics and dipped products; for which we employ a broad range of monomers. Weas a company have a strong interest in sustainable chemistries, ranging from active projects in the sourcing and evaluation of sustainable and new bio-derived raw materials, through to the possibilities of applying the concepts of process intensification to our manufacturing operations. (


    FORESA is a European chemical company with a strong interest in research and innovation which provides high quality technical, know-how technology transfer and environmental solutions to our customers. FORESA was founded in 1964 and, presently, has factories in 3 different countries (Spain, Portugal andFrance). Foresa has a R+D+i Department at the Headquarters in Caldas de Reis with a highly technical team of 12 people (Ph.D and MSc´s) working full time to provide technical and environmental solutions. Foresa´s commitment in R+D+i is significantly increasing our international projection through novel and innovative products, know-how transfer technologies and environmental solutions in Europe, Africa, South America and Asia. ( 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 642671